Intellectual Property Protection: Critical for Vaccine Innovation

Intellectual Property Protection: Critical for Vaccine Innovation

A healthcare worker prepares a syringe with the Moderna COVID-19 vaccine at a pop-up vaccination site in New York City, January 29, 2021. (Mike Segar/Reuters)

Patent rights were key to the unprecedentedly rapid development and rollout of COVID-19 vaccines.

Waiving intellectual property protections (including patents) for COVID-19 vaccines, which, as U.S. trade representative Katherine Tai announced Wednesday, the Biden administration supports, will if implemented prove disastrous for American innovation…

Report

Leave a Reply

Your email address will not be published. Required fields are marked *